Remove Clinical Trials Remove Radiology Remove Scientist
article thumbnail

Advancing and Safeguarding Clinical Research for a Better Tomorrow

Advarra

Institutional review boards (IRBs) play a crucial role in the ever-evolving field of clinical research. Innovations in fields such as immunotherapy, cancer and chronic diseases owe their existence to clinical trials, which judiciously test and evaluate safety and efficacy.

article thumbnail

Power to the Patient with Patient Generated Health Data

FDA Law Blog

Lenz, Principal Medical Device Regulation Expert — FDA’s Center for Devices and Radiological Health (CDRH) recently partnered with the Digital Medicine Society (DiMe) to host a two-day workshop to help advance the use of patient-generated health data (PGHD) to support improved clinical trials, medical device development, and regulatory science.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

World Cancer Day 2024: Trends in Oncology Research and More

XTalks

Clinical trials have demonstrated the potential of CRISPR/Cas9 in this field. It promotes unique insights and improvements in tumor biology understanding through the collaboration of biological and computer scientists.

Research 118
article thumbnail

Pandemic Has Greatly Slowed Pace of Cancer Research

The Pharma Data

“When the pandemic hit full force in March and April, scientists had not yet been able to adapt their processes to operate safely. And some scientists — the ones who were clinically trained — were then pulled to help meet the clinical [COVID-19-related] needs of their various institutions.

article thumbnail

Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024

Intouch Solutions

I mean, there was a great talk yesterday about AI in terms of not only that, what we’ve been hearing about over the years and the impact it’s going to have with pathology and radiology, but also now with medical oncologists and how it’s going. I have seen quite a few excited scientists, I must admit. Absolutely.

DNA 59
article thumbnail

Low-dose radiotherapy combined with immunotherapy eradicates metastatic cancer in mice

Bioengineer

“In clinical trials, we tend to go with the maximum tolerable dose, the idea being that radiation kills the cancer and the more we give, the better. . “In clinical trials, we tend to go with the maximum tolerable dose, the idea being that radiation kills the cancer and the more we give, the better.

article thumbnail

AstraZeneca’s COVID-19 vaccine; Type 1 diabetes research updates; FDA nod to Zebra’s X-ray modelling AI; UniQure/CSL haemophilia B gene therapy curbs bleeding in phase 3

Delveinsight

In a pooled analysis of 11,636 participants enrolled in two separate clinical trials in the U.K. trial came to give some subjects a half-dose primer and offers potential explanations for the effect but omits the key question of whether the regimen has 90% efficacy or not. The Lancet paper offers background on how the U.K.